Bhatia Sangeeta N. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Bhatia Sangeeta N. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $371K.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-05VRTXVERTEX PHARMACEUTICALS INC / MAS — Open-market sale318$423.73$135K
2026-05-05VRTXVERTEX PHARMACEUTICALS INC / MAA — Grant or award943$0.00
2026-02-18VRTXVERTEX PHARMACEUTICALS INC / MAS — Open-market sale [10b5-1]266$500.00$133K
2025-08-27VRTXVERTEX PHARMACEUTICALS INC / MAS — Open-market sale266$386.69$103K

Companies — Last 90 Days

Frequently Asked Questions

Who is Bhatia Sangeeta N.?

Bhatia Sangeeta N. is a corporate insider — currently tracked as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Bhatia Sangeeta N. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Bhatia Sangeeta N. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($371K) across all tracked filings.

Where can I see all of Bhatia Sangeeta N.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Bhatia Sangeeta N. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.